Clinical Trial Update: Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing hydroxychloroquine plus azithromycin versus hydroxychloroquine alone for COVID-19 pneumonia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Pneumonia Viral

Drugs mentioned

• Azithromycin (azithromycin)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Coronavirus Infection, Pneumonia, Viral | Phase 2, Phase 3 | Status: TERMINATED